Citation Impact
Citing Papers
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
2013
The prognostic value of baseline erosions in undifferentiated arthritis
2009
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
2005
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis
2010
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
2005
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
2010
The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis
2010
Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial
2006
Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
2004
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
2014
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
2008
Validation of a prediction rule for disease outcome in patients with recent‐onset undifferentiated arthritis: Moving toward individualized treatment decision‐making
2008
Rheumatoid arthritis
2018 Standout
Rheumatoid arthritis
2009
Changes Over Time in the Diagnosis of Rheumatoid Arthritis in a 10-year Cohort
2009
Promising bone-related therapeutic targets for rheumatoid arthritis
2009
Rheumatoid arthritis
2016 Standout
Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis
2011
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Parvovirus-associated arthritis
2000
Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin‐6 synthesis: Common pathway in inflammatory sequelae of human parvovirus infections?
2002
Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial
2008 Standout
When does rheumatoid arthritis begin and why do we need to know?
2000
Therapeutic Strategies for Rheumatoid Arthritis
2004
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
2009
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
2013
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials
2012
An update on methotrexate
2009
Periodontitis and Porphyromonas gingivalis in Preclinical Stage of Arthritis Patients
2015
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
2005
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983–2001
2004
Annual incidence of inflammatory joint diseases in a population based study in southern Sweden
2002
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis
2008
Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis
2011
Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis
2012
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
2005
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Crohn's disease
2016 Standout
Development of quality indicators for monitoring of the disease course in rheumatoid arthritis
2009
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: Findings of a prospective pilot study
2011
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
2007
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Immediate access rheumatology clinic: efficiency and outcomes
2011
Rheumatoid arthritis
2010 Standout
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
2018
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
2010
Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis
2008
A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice
2011 StandoutNobel
Infliximab in active early rheumatoid arthritis
2004
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
2015
Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?
2010
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
Anti-CCP antibodies: the past, the present and the future
2011
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis
2017
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity--the early RA network (ERAN)
2010
Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example
2014
Structure and signalling in the IL-17 receptor family
2009 Standout
A prediction rule for disease outcome in patients with Recent‐onset undifferentiated arthritis: How to guide individual treatment decisions
2007
Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities
2016
The burden of rheumatoid arthritis and access to treatment: a medical overview
2007
IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?
2007
Development and deployment of antigen arrays for investigation of B-cell fine specificity in autoimmune disease
2011
Can diagnostic triage by general practitioners or rheumatology nurses improve the positive predictive value of referrals to early arthritis clinics?
2003
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Parvovirus B19
2004 Standout
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis
2012
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence
2005
Development and deployment of antigen arrays for investigation of B-cell fine specificity in autoimmune disease
2012
The Overview on Effectiveness of Quality Enhancement for Enhancing Health Care and Professional Practice
2024 Standout
Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
2007 Nobel
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents
2009
Human Parvovirus B19
2002 Standout
Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis
2012
In Vivo Imaging of Matrix Metalloproteinase 12 and Matrix Metalloproteinase 13 Activities in the Mouse Model of Collagen‐Induced Arthritis
2013 StandoutNobel
Implementation of Treat‐to‐Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial
2017
Glucocorticoids in rheumatoid arthritis: current status and future studies
2020
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes
2015 Standout
Brief Report: Testosterone Is Protective in the Sexually Dimorphic Development of Arthritis and Lung Disease in SKG Mice
2013 StandoutNobel
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
2008
Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study
2012
Works of I. Speyer being referenced
DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis
2009
Prevention of group B streptococci transmission during delivery by vaginal application of chlorhexidine gel
1989
Technetium-99m Labelled Human Immunoglobulin Scintigraphy Predicts Rheumatoid Arthritis in Patients with Arthralgia
1996
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies
2001
Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study)
2013
Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial
2010
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trial
2007
Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial
2005
A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study
2013
Recruitment of patients with early rheumatoid arthritis -- the Netherlands experience.
1996
[Diagnosis and course of early arthritis; study in a specialized clinic for early arthritis].
1996
FRI0094 Outcomes of two years of remission steered treatment in early arthritis patients
2013
Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients.
1998
Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment
2016